Showing results (51-60 of 305) with videos related to

Sort By:
Pageof 31
The American Journal of Medicine|January 1, 1979
Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remissionG P Bodey, V Rodriguez, F Cabanillas, et al.
Annals of Internal Medicine|December 16, 1998
The clinical behavior of localized and multicentric Castleman diseaseJ Herrada, F Cabanillas, L Rice, et al.
Leukemia & Lymphoma|January 1, 1993
Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growthR J Ford, A Tamayo, D J Li, et al.
Leukemia & Lymphoma|August 26, 1998
High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphomaL Fayad, F Cabanillas, M Talpaz, et al.
Annals of Internal Medicine|February 1, 1995
Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphomaF Cabanillas, J Armitage, W C Pugh, et al.
Blood|September 1, 1982
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyF Cabanillas, F B Hagemeister, G P Bodey, et al.
Cancer Treatment Reports|March 1, 1979
Results of a phase II study of maytansine in patients with breast carcinoma and melanomaF Cabanillas, G P Bodey, M A Burgess, et al.
Blood|March 1, 1981
Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disordersF Cabanillas, S S Legha, G P Bodey, et al.
Hematological Oncology|January 1, 1995
Outcome of Hodgkin's disease in elderly patientsJ R Diaz-Pavon, F Cabanillas, A Majlis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphomaJ E Romaguera, W Pugh, R Luthra, et al.
Pageof 31